Lupin gets Health Canada clearance for Pithampur unit
New Delhi: Drug firm Lupin Ltd said its Pithampur unit 2 manufacturing facility located in Indore has been cleared by Health Canada after a review.
"Following the review, Health Canada has maintained the compliant rating for unit 2 at Pithampur (Indore) and has issued a revised 'Establishment License'," Lupin said in a BSE filing.
In November 2017, Lupin had received a warning letter from US Food and Drug Administration for its manufacturing facilities in Goa and Pithampur, Indore.
clearanceEstablishment LicenseHealth CanadaIndoreLupinmanufacturing facilityPithampur unitUS Food and Drug Administration
Source : PTINext Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd